U.S. Tech Hardware Stock News

In late February 2026, Delek Logistics Partners, LP reported full-year 2025 results showing revenue of US$1,013.32 million and net income of US$176.46 million, alongside record adjusted EBITDA of US$536 million and the commissioning of its Libby 2 gas processing plant. The partnership also marked its 52nd consecutive quarterly distribution increase and highlighted the growing contribution of its integrated crude, gas, and water midstream platform in the Permian Basin. We’ll now examine how...

In February 2026, Kimberly-Clark’s Kotex brand launched a fully reimagined range of pads and liners, introducing Gravity™ Core technology, a 5X System with LeakShield™, new BioCare and Bamboo lines, teen-focused and overnight products, and a bold visual identity, with nationwide US rollout across major retailers. This portfolio overhaul directly targets widespread consumer frustration with existing period products, aiming to differentiate Kotex through comfort-focused materials, odor and pH...

Five9 (FIVN) is back in focus after reporting Q4 and full year 2025 results, issuing 2026 guidance, and spotlighting enterprise AI growth that now exceeds a US$100 million annual run rate. See our latest analysis for Five9. Despite the earnings beat and fresh 2026 guidance, Five9’s recent 90 day share price return decline of 11.27% and 1 year total shareholder return decline of 49.33% suggest momentum has been under pressure, even as enterprise AI becomes a larger part of the story. If this...

Ardagh Metal Packaging (AMBP) has given investors plenty to think about after reporting 2025 results that exceeded its own guidance, outlining 2026 adjusted EBITDA growth expectations, completing a US$1.3b green bond refinancing, and affirming a quarterly dividend. See our latest analysis for Ardagh Metal Packaging. The recent earnings beat, 2026 EBITDA guidance and US$1.3b green bond refinancing sit against a share price of US$4.85, with a 30 day share price return of 10.48% and a 1 year...

Event overview and immediate context Generate Biomedicines (GENB) recently drew investor attention after a single day move of about 3.8% and a year to date return of roughly a 23.9% decline, prompting closer scrutiny of its drug discovery model and early stage pipeline. See our latest analysis for Generate Biomedicines. For now, the 1 day share price return of about 3.8% and year to date share price return of roughly a 23.9% decline suggest sentiment has cooled, even as interest in its...

If you are wondering whether American Express shares still offer value at current levels, this article will walk through what the numbers suggest and how that might fit your own expectations. The stock last closed at US$307.43, with returns of 5.1% over 1 year, 78.0% over 3 years and 117.3% over 5 years. The shorter term picture shows a 4.3% decline over 7 days, a 12.7% decline over 30 days and a 17.5% decline year to date. Recent headlines around American Express have kept attention on the...

LCI Industries (NYSE:LCII) has signaled ongoing interest in acquisitions, highlighting a renewed focus on M&A within its core markets. The company referenced a history of completed deals and expressed intentions to build on recent M&A momentum. This more active approach to acquisitions could influence LCI Industries' growth path, competitive position and capital deployment priorities. For investors watching NYSE:LCII, the renewed emphasis on acquisitions comes as the shares trade at...

Empire State Realty OP (ESBA) just wrapped up FY 2025 with Q4 total revenue of US$199.7 million and basic EPS of US$0.13, while trailing twelve month revenue sits at US$768.3 million and EPS at US$0.27. Over the past few quarters, revenue has moved from US$197.6 million in Q4 2024 to US$199.7 million in Q4 2025, with quarterly EPS shifting from US$0.07 to US$0.13. This sets up a picture where investors will be weighing these earnings against a 9.5% net margin and the impact of a one off gain...

Wix.com (WIX) is back in focus as investors position ahead of its March 4 earnings release, while the company rolls out new AI powered tools and integrations with Google and Intuit that aim to deepen its role in online commerce. See our latest analysis for Wix.com. With the share price at US$72.56, Wix.com has seen a 2.98% 1 day share price return and a 15.54% 7 day share price return, but a 24.31% 90 day share price decline and a 61.68% 1 year total shareholder return decline suggest...

CAVA Group (CAVA) drew sharp investor attention after its fourth quarter earnings and 2026 outlook, which paired strong restaurant expansion plans with new menu items and a projected 3% to 5% increase in same restaurant sales. See our latest analysis for CAVA Group. Over the past year, CAVA Group has paired upbeat earnings headlines and expansion plans with sharp share price swings, including a 29.5% 30 day share price return and a 48.9% 90 day share price return. Its 1 year total shareholder...

In February 2026, Intuitive Machines, Inc. completed a private placement of 11,574,074 Class A shares at US$15.12 each, raising about US$175,000,000 from global institutional investors in a transaction exempt from Securities Act registration. The equity raise follows the largely cash-funded Lanteris acquisition and is intended to replenish the balance sheet while accelerating investment in Near Space Network Services, Lanteris satellite platforms, and a “solar system internet” spanning Earth...

Investors may be wondering whether Kroger, at around its recent US$69.05 close, is still a reasonable entry point or if most of the easy value is already on the table. The stock has returned 1.2% over the last 7 days, 9.9% over the past month, 9.7% year to date, 12.0% over 1 year, 58.7% over 3 years and 121.0% over 5 years. These returns may have shifted how the market views its risk and return trade off. Recent coverage has focused on Kroger's ongoing position as a major US grocery chain...

In recent months, Progressive reported higher net premiums written and earned, stronger underwriting margins with an improved combined ratio, and broad policy growth across personal, commercial, and property lines. An interesting angle is how its push into digital and direct-to-consumer channels appears to be amplifying this operational momentum across the entire franchise. Next, we’ll examine how this improved combined ratio and premium growth may influence Progressive’s existing investment...

Activist pressure puts ASA Gold and Precious Metals in focus Saba Capital Management LP has urged ASA Gold and Precious Metals (ASA) to conduct a comprehensive review, with an updated February 19 presentation outlining clarified alternatives for the Board to evaluate. For you as an investor, this kind of activist communication often raises questions around portfolio structure, capital allocation and potential changes that could affect how ASA trades relative to its underlying precious metals...

In February 2026, Kratos Defense & Security Solutions announced a US$12.40 million U.S. Air Force contract with GE Aerospace to complete preliminary design work on the GEK1500 next-generation 1,500‑lb thrust engine for small collaborative combat aircraft and unmanned systems, while Starfighters Space moved its STARLAUNCH 1 rocket program into Critical Design Review with GE Aerospace support. Together, these projects highlight GE Aerospace’s expanding role in affordable, high-performance...

Why Ouster’s latest earnings matter for investors Ouster (OUST) reported fourth quarter revenue of US$62.18 million and net income of US$3.99 million, compared with US$30.09 million revenue and a net loss of US$23.74 million a year earlier. Basic earnings per share from continuing operations came in at US$0.07, with diluted EPS at US$0.06, versus a basic and diluted loss of US$0.48 per share in the prior year period. See our latest analysis for Ouster. The earnings beat and the recently...

If you are wondering whether MetLife’s current share price reflects its true worth, this article explains how the market might be pricing the stock today. MetLife last closed at US$73.24, with returns of a 2.7% decline over 7 days, a 7.2% decline over 30 days, an 8.8% decline year to date, and a 12.0% decline over 1 year, compared with gains of 15.3% over 3 years and 41.2% over 5 years. These mixed returns sit against a backdrop of ongoing news coverage around the company’s position as a...

D-Wave Quantum (QBTS) has drawn fresh attention as investors reassess this US quantum computing provider after recent share price swings and a mixed return profile, including a 1-day gain alongside weaker performance over the past month and past 3 months. See our latest analysis for D-Wave Quantum. At the current share price of $18.94, D-Wave Quantum shows a 7-day share price return of 4.93% and a 90-day share price return of 15.82%. The 1-year total shareholder return remains very large,...

In late February 2026, Illumina, Inc. launched its TruPath Genome whole‑genome workflow and expanded Illumina Laboratory Services to support Florida State University’s new pediatric rare disease diagnostic lab with clinical sequencing and interpretation. Together, these moves pair higher‑resolution sequencing technology with real‑world clinical deployment, underscoring Illumina’s push to make advanced rare disease diagnostics more accessible and operationally efficient for hospitals and...

Roku (ROKU) just followed up a stronger fourth quarter with a slot at Bernstein’s “What’s next in tech?” forum, giving investors fresh context on its earnings, platform reach, and position as a neutral streaming aggregator. See our latest analysis for Roku. Roku’s recent 16.2% 7 day share price return and 22.2% 1 year total shareholder return sit against a weaker year to date share price return of 9.8% decline, suggesting momentum has picked up again around its earnings and platform...

Nuvation Bio (NUVB) just finalized a protocol amendment that advances its global SIGMA safusidenib study into Phase 3, widening access for high risk IDH1 mutant astrocytoma patients and drawing additional investor attention to upcoming earnings. See our latest analysis for Nuvation Bio. The share price, now at US$5.84, has a 7 day share price return of 7% and a 30 day share price return of 11%, but a 90 day share price return of a 22% decline. The 1 year total shareholder return is over 3x...

UroGen Pharma FY 2025 results set the stage for growth versus losses debate UroGen Pharma (URGN) closed out FY 2025 with Q4 revenue of US$37.8 million and a basic EPS loss of US$0.54, alongside a trailing twelve month loss of US$3.19 per share on US$109.8 million of revenue. The company has seen quarterly revenue move from US$24.6 million in Q4 2024 to US$37.8 million in Q4 2025. Over the same period, basic EPS ranged from a loss of US$1.05 in Q2 2025 to a loss of US$0.54 in the latest...

Why KLA (KLAC) is on investors’ radar right now KLA (KLAC) has drawn fresh attention after its recent share move, with the stock last closing at US$1,534.95 and delivering a 7.5% return over the past month and 29% in the past 3 months. See our latest analysis for KLA. Beyond the recent move, KLA’s momentum has been building, with a 7 day share price return of 3.2%, a 30 day return of 7.5% and a 1 year total shareholder return of about 124%, pointing to strong recent enthusiasm for the...

Quantum Computing Inc. (NasdaqCM:QUBT) has completed its acquisition of Luminar Semiconductor and opened a major quantum chip foundry. The company has reported first commercial sales of its quantum cybersecurity solutions, including a contract with a major U.S. bank. Quantum Computing Inc. is collaborating with NASA under a subcontract and plans to expand its manufacturing capacity. Quantum Computing Inc. (NasdaqCM:QUBT), trading at $8.59, is shifting from a pure technology developer toward...